Tacrolimus 0.1% vs mometasone furoate ointment
Primary outcome 3: Adverse events · people with moderate to severe chronic relapsing dyshidrotic eczema on hands
1 finding from 1 review
- no estimate extracted1 study · 16 participantsModerate
Findings
What do systematic reviews say?
2 questions · 2 findings · 1 reviews
No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 2 · 100%High 0 · 0%
Tacrolimus 0.1% vs vehicle
Primary: adverse events ‐ burning/itching at application site · people with moderate to severe nickel sulphate‐induced allergic contact dermatitis based on clinical history (hand eczema) and proven by…
Topical calcineurin inhibitors: tacrolimus 0.1% ointment showed no clear difference in primary: adverse events ‐ burning/itching at application site compared with vehicle (moderate certainty).
1 finding from 1 review
- RR 9 [0.53, 152.93]1 study · 28 participantsModerate